EIR Bayer Healthcare Pharmaceuticals Dec 2000

Russell Glapion FDA, Donald Lech FDA$595.00 - Available Now

FDA investigators audited the Bayer Healthcare Pharmaceuticals - Whippany, NJ, United States facility and issued inspectional observation (via FDA 483) on 05 Dec 2000.

Product details

  • Category:
  • Inspection end: 05 Dec 2000
  • Location: Whippany, United States
  • FEI: 2243252
Add To Cart